Product Information
FELODIPINE ER 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1352 per EA under NDC 57237011001. Its NADAC has been published 557 times since Mar 18, 2015.
FDA first approved this application on Jan 17, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237011001
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FELODIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA203417FDA Approved
1/17/2013
TE Code
AB
On Market Since
1/17/2013
Pharmacological Classes
Price Statistics
The NADAC for FELODIPINE ER 10 MG TABLET has been published 557 times since Mar 18, 2015, and over the history we have for it it has declined 76.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1352 per EA |
|---|---|
| All-time high | $0.5660 (Apr 15, 2015) |
| All-time low | $0.1117 (Jun 17, 2026) |
| 52-week high | $0.1701 |
| 52-week low | $0.1117 |
| Median price | $0.2475 |
| Average price | $0.2626 |
| Largest weekly change | +56.6% (Mar 20, 2024) |
| Weeks tracked | 557 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Felodipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FELODIPINE ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FELODIPINE ER 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1352 per EA (NDC 57237011001), effective Sep 30, 2026.
How has the price of FELODIPINE ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for FELODIPINE ER 10 MG TABLET has declined 76.1%. It has been tracked across 557 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for FELODIPINE ER 10 MG TABLET?
Since Mar 18, 2015, the NADAC for FELODIPINE ER 10 MG TABLET has ranged from a low of $0.1117 (Jun 17, 2026) to a high of $0.5660 (Apr 15, 2015), with a median of $0.2475 per EA.
Are there cheaper alternatives to FELODIPINE ER 10 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FELODIPINE ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FELODIPINE ER 10 MG TABLET?
FELODIPINE ER 10 MG TABLET (NDC 57237011001) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.